J, L., W, Z., Q, G., Y, Z., Z, G., & W, L. (2021). Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients. Dove Medical Press.
Cita Chicago Style (17a ed.)J, Liu, Zhao W, Gui Q, Zhang Y, Guo Z, y Liu W. Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients. Dove Medical Press, 2021.
Cita MLA (8a ed.)J, Liu, et al. Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.